Perceptive Advisors Llc Buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Sells DexCom, Aerie Pharmaceuticals, Depomed
March 20, 2017 | About: NBIX +0% ACRS +0% FOLD +0% ANIP +0% AVXS +0% GBT +0% GLPG +0% AVDL +0% ACOR +0% IRTC +0% C +0%
New York, NY, based Investment company Perceptive Advisors Llc buys Neurocrine Biosciences, Aclaris Therapeutics, Galapagos NV, Amicus Therapeutics, ANI Pharmaceuticals, Avadel Pharmaceuticals PLC, Acorda Therapeutics, AveXis, Global Blood Therapeutics, Ardelyx, sells DexCom, Aerie Pharmaceuticals, Depomed, Corbus Pharmaceuticals Holdings, Abiomed during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Perceptive Advisors Llc. As of 2016-12-31, Perceptive Advisors Llc owns 191 stocks with a total value of $1.4 billion. These are the details of the buys and sells.
New Purchases: GLPG, AVDL, ACOR, IRTC, CTMX, BCRX, ATRS, JAZZ, ALNY, PPHMP,
Added Positions: NBIX, ACRS, FOLD, ANIP, AVXS, GBT, ARDX, VBIV, ZGNX, XNCR,
Reduced Positions: SRPT, AERI, CRBP, ABMD, SUPN, AGEN, BPMC, NDRM, AGTC, CEMP,
Sold Out: DXCM, DEPO, ACHN, PTI, AMRN, ANTH, CLLS, BGNE, MYL, ACAD,
Nogmaals op marketwatch